Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Liliana Rodrigues, Pedro Cravo & Miguel Viveiros. (2020) Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs. Expert Review of Anti-infective Therapy 18:8, pages 741-757.
Read now
Read now
Articles from other publishers (21)
Gustavo Adolfo Bermudez-Hernández, Damián Eduardo Pérez-Martínez, Carlos Francisco Madrazo-Moya, Irving Cancino-Muñoz, Iñaki Comas & Roberto Zenteno-Cuevas. (2022) Whole genome sequencing analysis to evaluate the influence of T2DM on polymorphisms associated with drug resistance in M. tuberculosis. BMC Genomics 23:1.
Crossref
Crossref
Ya’nan Ren, Chen Liu, Teli Liu, Xiaojiang Duan, Qian Zhang, Jiayue Liu, Pei Wang, Qian Guo, Xing Yang, Peng Du, Hua Zhu & Zhi Yang. (2022) Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer. Frontiers in Oncology 12.
Crossref
Crossref
Ali A. Rabaan, Abbas Al Mutair, Hawra Albayat, Jawaher Alotaibi, Tarek Sulaiman, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Alfaraj, Mona A. Al Fares, Sara Alwarthan, Abdulwahab Z. Binjomah, Mohammed S. Alzahrani, Hatem M. Alhani, Mohammed S. Almogbel, Abdulmonem A. Abuzaid, Ghaya Alqurainees, Fatimah Al Ibrahim, Ali H. Alhaddad, Mubarak Alfaresi, Nadira Al-baghli & Saad Alhumaid. (2022) Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis. Molecules 27:20, pages 6985.
Crossref
Crossref
David Kajoba Mumena, Geoffrey Kwenda, Caroline Wangari Ngugi & Andrew Kimang’a Nyerere. (2022) Drug-target genes and their spontaneous mutations associated with resistance to first-line, second-line, third-line, novel and repurposed anti-tuberculosis drugs in Mycobacterium tuberculosis resistant strains. IP International Journal of Medical Microbiology and Tropical Diseases 8:3, pages 196-204.
Crossref
Crossref
Ali A. Rabaan, Saad Alhumaid, Hawra Albayat, Mohammed Alsaeed, Fadwa S. Alofi, Mawaheb H. Al-Howaidi, Safaa A. Turkistani, Salah M. Alhajri, Hejji E. Alahmed, Abdulwahab B. Alzahrani, Mutaib M. Mashraqi, Sara Alwarthan, Mashael Alhajri, Fatimah S. Alshahrani, Souad A. Almuthree, Roua A. Alsubki, Abdulmonem A. Abuzaid, Mubarak Alfaresi, Mona A. Al Fares & Abbas Al Mutair. (2022) Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules 27:16, pages 5335.
Crossref
Crossref
Anirudh Gairola, Aaron Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo & Hung‐Jen Wu. (2022) Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. Advanced Therapeutics 5:6, pages 2100193.
Crossref
Crossref
Navisha Dookie, Azraa Khan, Nesri Padayatchi & Kogieleum Naidoo. (2022) Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field. Frontiers in Microbiology 13.
Crossref
Crossref
Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, Crystale Siew Ying Lim, Fazlina Nordin & Gee Jun Tye. (2022) The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic. Frontiers in Immunology 13.
Crossref
Crossref
Tanushree Tunstall, Jody Phelan, Charlotte Eccleston, Taane G. Clark & Nicholas Furnham. (2021) Structural and Genomic Insights Into Pyrazinamide Resistance in Mycobacterium tuberculosis Underlie Differences Between Ancient and Modern Lineages. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Dillon Muzondiwa, Hleliwe Hlanze & Oleg N. Reva. (2021) The Epistatic Landscape of Antibiotic Resistance of Different Clades of Mycobacterium tuberculosis. Antibiotics 10:7, pages 857.
Crossref
Crossref
Aditi Chauhan, Manoj Kumar, Awanish Kumar & Kajal Kanchan. (2021) Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs. Life Sciences 274, pages 119301.
Crossref
Crossref
Anna Allué-Guardia, Juan I. García & Jordi B. Torrelles. (2021) Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Frontiers in Microbiology 12.
Crossref
Crossref
Kai Ling Chin, Maria E. Sarmiento, Zainal Arifin Mustapha, Jaeyres Jani, Norfazirah Binti Jamal, Cheronie Shely Stanis & Armando Acosta. (2020) Identification of a Mycobacterium tuberculosis-specific gene marker for diagnosis of tuberculosis using semi-nested melt-MAMA qPCR (lprM-MAMA). Tuberculosis 125, pages 102003.
Crossref
Crossref
Erika A. Peláez Coyotl, Jacqueline Barrios Palacios, Gabriel Muciño, Daniel Moreno-Blas, Miguel Costas, Teresa Montiel Montes, Christian Diener, Salvador Uribe-Carvajal, Lourdes Massieu, Susana Castro-Obregón, Octavio Ramos Espinosa, Dulce Mata Espinosa, Jorge Barrios-Payan, Juan Carlos León Contreras, Gerardo Corzo, Rogelio Hernández-Pando & Gabriel Del Rio. (2020) Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis. Pharmaceutics 12:11, pages 1071.
Crossref
Crossref
Giovana F Costacurta, Mariana RP Souza, Eloísa G Sampiron, Aryadne L Almeida, Vanessa P Baldin, Andressa L Ieque, Nathally CS Santos, Pedro HR Amaral, Cleuza C Silva, Vera LD Siqueira, Katiany R Caleffi-Ferracioli, Rosilene F Cardoso, Fábio Vandresen & Regiane BL Scodro. (2020)
Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against
Mycobacterium tuberculosis
. Future Microbiology 15:9, pages 723-738.
Crossref
Crossref
R. Singh, S.P. Dwivedi, U.S. Gaharwar, R. Meena, P. Rajamani & T. Prasad. (2019)
Recent updates on drug resistance in
Mycobacterium tuberculosis
. Journal of Applied Microbiology 128:6, pages 1547-1567.
Crossref
Crossref
Bahman Mohammadi, Rashid Ramazanzadeh, Bijan Nouri & Samaneh Rouhi. (2020) Frequency of Codon 306 Mutations in embB Gene of Mycobacterium tuberculosis Resistant to Ethambutol: A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine 11:1, pages 112.
Crossref
Crossref
Vijay Kumar, Simranjeet Singh, Daljeet Singh, Shivika Datta, Sanjay Kumar, Shyam Babu Singh & Joginder Singh. 2020. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery
301
322
.
Christian David Sánchez-Barinas, Marisol Ocampo, Luisa Tabares, Maritza Bermúdez, Manuel Alfonso Patarroyo & Manuel Elkin Patarroyo. (2019)
Specific Binding Peptides from Rv3632: A Strategy for Blocking
Mycobacterium tuberculosis
Entry to Target Cells?
. BioMed Research International 2019, pages 1-13.
Crossref
Crossref
Sheng Zeng, Karine Soetaert, Faustine Ravon, Marie Vandeput, Dirk Bald, Jean-Michel Kauffmann, Vanessa Mathys, Ruddy Wattiez & Véronique Fontaine. (2019) Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation. Antimicrobial Agents and Chemotherapy 63:3.
Crossref
Crossref
Stephanie Portelli, Jody E. Phelan, David B. Ascher, Taane G. Clark & Nicholas Furnham. (2018) Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis. Scientific Reports 8:1.
Crossref
Crossref